Global Pneumonia Vaccine Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID :QYR-14070062 | Published Date: 10-Apr-2019 | No. of pages: 137Description
TOC
Table of Contents
1 Pneumonia Vaccine Market Overview
1.1 Pneumonia Vaccine Product Overview
1.2 Pneumonia Vaccine Market Segment by Type
1.2.1 Pneumococcal Conjugate Vaccine (PCV13)
1.2.2 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.3 Global Pneumonia Vaccine Market Size by Type
1.3.1 Global Pneumonia Vaccine Sales and Growth by Type
1.3.2 Global Pneumonia Vaccine Sales and Market Share by Type (2014-2019)
1.3.3 Global Pneumonia Vaccine Revenue and Market Share by Type (2014-2019)
1.3.4 Global Pneumonia Vaccine Price by Type (2014-2019)
2 Global Pneumonia Vaccine Market Competition by Company
2.1 Global Pneumonia Vaccine Sales and Market Share by Company (2014-2019)
2.2 Global Pneumonia Vaccine Revenue and Share by Company (2014-2019)
2.3 Global Pneumonia Vaccine Price by Company (2014-2019)
2.4 Global Top Players Pneumonia Vaccine Manufacturing Base Distribution, Sales Area, Product Types
2.5 Pneumonia Vaccine Market Competitive Situation and Trends
2.5.1 Pneumonia Vaccine Market Concentration Rate
2.5.2 Global Pneumonia Vaccine Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Pneumonia Vaccine Company Profiles and Sales Data
3.1 Pfizer Inc.
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Pneumonia Vaccine Product Category, Application and Specification
3.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Glaxosmithkline Plc.
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Pneumonia Vaccine Product Category, Application and Specification
3.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Merck & Co., Inc.
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Pneumonia Vaccine Product Category, Application and Specification
3.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Sanofi Pasteur
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Pneumonia Vaccine Product Category, Application and Specification
3.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Serum Institute of India Pvt. Ltd.
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Pneumonia Vaccine Product Category, Application and Specification
3.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Johnson & Johnson
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Pneumonia Vaccine Product Category, Application and Specification
3.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Astellas Pharma Inc.
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Pneumonia Vaccine Product Category, Application and Specification
3.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Astrazeneca Plc.
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Pneumonia Vaccine Product Category, Application and Specification
3.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 CSL Limited
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Pneumonia Vaccine Product Category, Application and Specification
3.9.3 CSL Limited Pneumonia Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Emergent Biosolutions
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Pneumonia Vaccine Product Category, Application and Specification
3.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
4 Pneumonia Vaccine Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Pneumonia Vaccine Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Pneumonia Vaccine Sales and Revenue by Regions
4.2.1 Global Pneumonia Vaccine Sales and Market Share by Regions (2014-2019)
4.2.2 Global Pneumonia Vaccine Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Pneumonia Vaccine Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Pneumonia Vaccine Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Pneumonia Vaccine Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Pneumonia Vaccine Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Pneumonia Vaccine Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Pneumonia Vaccine Application/End Users
5.1 Pneumonia Vaccine Segment by Application
5.1.1 Pneumonia
5.1.2 Meningitis
5.1.3 Sepsis
5.2 Global Pneumonia Vaccine Product Segment by Application
5.2.1 Global Pneumonia Vaccine Sales by Application
5.2.2 Global Pneumonia Vaccine Sales and Market Share by Application (2014-2019)
6 Global Pneumonia Vaccine Market Forecast
6.1 Global Pneumonia Vaccine Sales, Revenue Forecast (2019-2025)
6.1.1 Global Pneumonia Vaccine Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Pneumonia Vaccine Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Pneumonia Vaccine Forecast by Regions
6.2.1 North America Pneumonia Vaccine Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Pneumonia Vaccine Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Pneumonia Vaccine Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Pneumonia Vaccine Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Pneumonia Vaccine Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Pneumonia Vaccine Forecast by Type
6.3.1 Global Pneumonia Vaccine Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Pneumococcal Conjugate Vaccine (PCV13) Gowth Forecast
6.3.3 Pneumococcal Polysaccharide Vaccine (PPSV23) Gowth Forecast
6.4 Pneumonia Vaccine Forecast by Application
6.4.1 Global Pneumonia Vaccine Sales Forecast by Application (2019-2025)
6.4.2 Global Pneumonia Vaccine Forecast in Pneumonia
6.4.3 Global Pneumonia Vaccine Forecast in Meningitis
7 Pneumonia Vaccine Upstream Raw Materials
7.1 Pneumonia Vaccine Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Pneumonia Vaccine Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
Tables & Figures
List of Tables and Figures
Figure Pneumonia Vaccine Product Picture
Figure Global Pneumonia Vaccine Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Pneumonia Vaccine Sales (K Doses) Status and Outlook (2014-2025)
Figure Product Picture of Pneumococcal Conjugate Vaccine (PCV13)
Table Major Players of Pneumococcal Conjugate Vaccine (PCV13)
Figure Global Pneumococcal Conjugate Vaccine (PCV13) Sales (K Doses) and Growth Rate (%)(2014-2018)
Figure Product Picture of Pneumococcal Polysaccharide Vaccine (PPSV23)
Table Major Players of Pneumococcal Polysaccharide Vaccine (PPSV23)
Figure Global Pneumococcal Polysaccharide Vaccine (PPSV23) Sales (K Doses) and Growth Rate (%)(2014-2019)
Table Global Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Comparison by Type
Table Global Pneumonia Vaccine Sales (K Doses) by Type (2014-2019)
Table Global Pneumonia Vaccine Sales Share (%) by Type (2014-2019)
Figure Global Pneumonia Vaccine Sales Market Share (%) by Type (2014-2019)
Figure Global Pneumonia Vaccine Sales Market Share (%) by Type in 2018
Table Global Pneumonia Vaccine Revenue (Million USD) by Type (2014-2019)
Table Global Pneumonia Vaccine Revenue Share (%) by Type (2014-2019)
Figure Global Pneumonia Vaccine Revenue Share (%) by Type (2014-2019)
Figure 2018 Global Pneumonia Vaccine Revenue Market Share (%) by Type
Table Global Pneumonia Vaccine Price (USD/Dose) by Type (2014-2019)
Table Global Pneumonia Vaccine Sales (K Doses) by Company (2014-2019)
Table Global Pneumonia Vaccine Sales Share (%) by Company (2014-2019)
Figure Global Pneumonia Vaccine Sales Share (%) by Company in 2018
Table Global Pneumonia Vaccine Revenue (Million USD) by Company (2014-2019)
Table Global Pneumonia Vaccine Revenue Share (%) by Company (2014-2019)
Figure Global Pneumonia Vaccine Revenue Share (%) by Company in 2018
Table Global Market Pneumonia Vaccine Average Price (USD/Dose) by Company (2014-2019)
Table Global Pneumonia Vaccine Top Players Manufacturing Base Distribution and Sales Area
Table Global Pneumonia Vaccine Top Players Product Category
Figure Global Pneumonia Vaccine Market Share (%) of Top 5 Players
Figure Global Pneumonia Vaccine Market Share (%) of Top 10 Players
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Pneumonia Vaccine Product Category, Application and Specification
Table Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Pfizer Inc. Pneumonia Vaccine Sales Growth Rate (2014-2019)
Figure Pfizer Inc. Pneumonia Vaccine Sales Global Market Share (%)(2014-2019)
Table Glaxosmithkline Plc. Basic Information List
Figure Glaxosmithkline Plc. Pneumonia Vaccine Product Category, Application and Specification
Table Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Glaxosmithkline Plc. Pneumonia Vaccine Sales Growth Rate (2014-2019)
Figure Glaxosmithkline Plc. Pneumonia Vaccine Sales Global Market Share (%)(2014-2019)
Table Merck & Co., Inc. Basic Information List
Figure Merck & Co., Inc. Pneumonia Vaccine Product Category, Application and Specification
Table Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Merck & Co., Inc. Pneumonia Vaccine Sales Growth Rate (2014-2019)
Figure Merck & Co., Inc. Pneumonia Vaccine Sales Global Market Share (%)(2014-2019)
Table Sanofi Pasteur Basic Information List
Figure Sanofi Pasteur Pneumonia Vaccine Product Category, Application and Specification
Table Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Sanofi Pasteur Pneumonia Vaccine Sales Growth Rate (2014-2019)
Figure Sanofi Pasteur Pneumonia Vaccine Sales Global Market Share (%)(2014-2019)
Table Serum Institute of India Pvt. Ltd. Basic Information List
Figure Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Category, Application and Specification
Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales Growth Rate (2014-2019)
Figure Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales Global Market Share (%)(2014-2019)
Table Johnson & Johnson Basic Information List
Figure Johnson & Johnson Pneumonia Vaccine Product Category, Application and Specification
Table Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Johnson & Johnson Pneumonia Vaccine Sales Growth Rate (2014-2019)
Figure Johnson & Johnson Pneumonia Vaccine Sales Global Market Share (%)(2014-2019)
Table Astellas Pharma Inc. Basic Information List
Figure Astellas Pharma Inc. Pneumonia Vaccine Product Category, Application and Specification
Table Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Astellas Pharma Inc. Pneumonia Vaccine Sales Growth Rate (2014-2019)
Figure Astellas Pharma Inc. Pneumonia Vaccine Sales Global Market Share (%)(2014-2019)
Table Astrazeneca Plc. Basic Information List
Figure Astrazeneca Plc. Pneumonia Vaccine Product Category, Application and Specification
Table Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Astrazeneca Plc. Pneumonia Vaccine Sales Growth Rate (2014-2019)
Figure Astrazeneca Plc. Pneumonia Vaccine Sales Global Market Share (%)(2014-2019)
Table CSL Limited Basic Information List
Figure CSL Limited Pneumonia Vaccine Product Category, Application and Specification
Table CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure CSL Limited Pneumonia Vaccine Sales Growth Rate (2014-2019)
Figure CSL Limited Pneumonia Vaccine Sales Global Market Share (%)(2014-2019)
Table Emergent Biosolutions Basic Information List
Figure Emergent Biosolutions Pneumonia Vaccine Product Category, Application and Specification
Table Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Emergent Biosolutions Pneumonia Vaccine Sales Growth Rate (2014-2019)
Figure Emergent Biosolutions Pneumonia Vaccine Sales Global Market Share (%)(2014-2019)
Table Global Pneumonia Vaccine Market Size Comparison by Regions (2014-2025)
Figure North America Pneumonia Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific Pneumonia Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe Pneumonia Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America Pneumonia Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa Pneumonia Vaccine Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global Pneumonia Vaccine Sales (K Doses) by Regions (2014-2019)
Table Global Pneumonia Vaccine Sales Market Share (%) by Regions (2014-2019)
Figure Global Pneumonia Vaccine Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global Pneumonia Vaccine Sales Market Share (%) by Regions
Table Global Pneumonia Vaccine Revenue (Million USD) by Regions (2014-2019)
Table Global Pneumonia Vaccine Revenue Market Share (%) by Regions (2014-2019)
Figure Global Pneumonia Vaccine Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global Pneumonia Vaccine Revenue Market Share (%) by Regions
Table Global Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure North America Pneumonia Vaccine Sales Growth Rate
Table North America Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure United States Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure United States Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Canada Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Canada Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Mexico Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Mexico Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Europe Pneumonia Vaccine Sales Growth Rate
Table Europe Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Germany Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Germany Pneumonia Vaccine Revenue (Million USD) (2014-2019)
Figure UK Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure UK Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure France Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure France Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Italy Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Italy Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Russia Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Russia Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Turkey Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Turkey Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Pneumonia Vaccine Sales Growth Rate
Table Asia-Pacific Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure China Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure China Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Japan Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Japan Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Korea Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Korea Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Southeast Asia Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Southeast Asia Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Indonesia Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Indonesia Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Thailand Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Thailand Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Malaysia Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Malaysia Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Philippines Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Philippines Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Vietnam Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Vietnam Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure India Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure India Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Australia Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Australia Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure South America Pneumonia Vaccine Sales Growth Rate
Table South America Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure Brazil Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure Brazil Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Middle East and Africa Pneumonia Vaccine Sales Growth Rate
Table Middle East and Africa Pneumonia Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2014-2019)
Figure North Africa Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure North Africa Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure GCC Countries Pneumonia Vaccine Sales (K Doses)(2014-2019)
Figure GCC Countries Pneumonia Vaccine Revenue (Million USD)(2014-2019)
Figure Pneumonia Examples
Figure Meningitis Examples
Figure Sepsis Examples
Table Global Pneumonia Vaccine Sales (K Doses) Comparison by Application (2014-2025)
Table Global Pneumonia Vaccine Sales (K Doses) by Application (2014-2019)
Table Global Pneumonia Vaccine Sales Share (%) by Application (2014-2019)
Figure Global Pneumonia Vaccine Sales Market Share (%) by Application (2014-2019)
Figure Global Pneumonia Vaccine Sales Market Share (%) by Application in 2018
Figure Global Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Global Pneumonia Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Pneumonia Vaccine Sales (K Doses) Forecast by Regions (2019-2025)
Figure Global Pneumonia Vaccine Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure North America Pneumonia Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Pneumonia Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Pneumonia Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure China Pneumonia Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Japan Pneumonia Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Korea Pneumonia Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Pneumonia Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure India Pneumonia Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Australia Pneumonia Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure South America Pneumonia Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Pneumonia Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Pneumonia Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Pneumonia Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Pneumonia Vaccine Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global Pneumonia Vaccine Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Pneumonia Vaccine Sales Market Share (%) Forecast by Type (2019-2025)
Table Global Pneumonia Vaccine Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Pneumonia Vaccine Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Pneumococcal Conjugate Vaccine (PCV13) Sales Growth Forecast
Figure Pneumococcal Polysaccharide Vaccine (PPSV23) Sales Growth Forecast
Table Global Pneumonia Vaccine Sales (K Doses) Forecast by Application (2019-2025)
Figure Global Pneumonia Vaccine Sales Forecast by Application (2019-2025)
Figure Global Pneumonia Vaccine Sales (K Doses) Forecast in Pneumonia
Figure Global Pneumonia Vaccine Sales (K Doses) Forecast in Meningitis
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Pneumonia Vaccine Manufacturing Cost Structure
Figure Pneumonia Vaccine Industrial Chain Analysis
Table Distributors List
Table Pneumonia Vaccine Downstream Customers
Companies
Pfizer Inc.
Glaxosmithkline Plc.
Merck & Co., Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Johnson & Johnson
Astellas Pharma Inc.
Astrazeneca Plc.
CSL Limited
Emergent Biosolutions
- PRICE
-
$3350$6700$5025Buy Now